Clinical Trial Update: Efficacy of Chemotherapy, Associated to Either Cetuximab or Bevacizumab, in KRAS Wild-type Metastatic Colorectal Cancer Patients With Progressive Disease After Receiving First-line Treatment With Bevacizumab [Phase 2]

View source ↗

Summary

Phase 2 trial assessing chemotherapy plus either cetuximab or bevacizumab in KRAS wild-type metastatic colorectal cancer after progression on first-line bevaciz…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Cetuximab (cetuximab)

Snippet

Sponsor: UNICANCER | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED